We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Biocartis’ KRAS Mutation Test Receives CE-IVD Marking

Product News   Jun 24, 2015

 
Biocartis’ KRAS Mutation Test Receives CE-IVD Marking
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Thermo Fisher Expands GlobalAccess Sequencing Program to Oncology Labs

Product News

The company has extended program benefits to oncology laboratories and fast-tracking access to comprehensive molecular profiling on the Genexus System.

READ MORE

Cancer Research UK and Abcam Launch Custom Antibody Partnership to Accelerate Research

Product News

Cancer Research UK and Abcam plc have announced a new partnership for the development and commercialization of novel custom antibodies to support the acceleration of cancer research.

READ MORE

Byondis’ Investigational Antibody-Drug Conjugate Selected for Trial in Early-Stage Breast Cancer

Product News

Byondis has announced that Quantum Leap selected the company’s investigational antibody-drug conjugate SYD985 for a new investigational treatment arm in its ongoing I-SPY 2 TRIAL™ for neoadjuvant treatment of locally advanced breast cancer.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE